Voloridge Investment Management
GTHX

Voloridge Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Voloridge Investment Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-150,930
Closed -$820K – 1664
2022
Q4 		$820K Sell
150,930
-177,870
-54% -$1.49M ﹤0.01% 1175
2022
Q3 		$4.11M Buy
+328,800
New +$3.76M 0.02% 714
2022
Q1 		– Sell
-33,859
Closed -$346K – 1772
2021
Q4 		$346K Sell
33,859
-208,094
-86% -$2.65M ﹤0.01% 1457
2021
Q3 		$3.25M Sell
241,953
-105,171
-30% -$1.71M 0.02% 858
2021
Q2 		$7.62M Buy
347,124
+3,758
+1% +$83.5K 0.05% 492
2021
Q1 		$8.26M Buy
343,366
+84,589
+33% +$1.97M 0.06% 396
2020
Q4 		$4.66M Buy
258,777
+239,423
+1,237% +$3.58M 0.04% 478
2020
Q3 		$224K Buy
+19,354
New +$319K ﹤0.01% 1183
2020
Q2 		– Sell
-18,943
Closed -$209K – 1563
2020
Q1 		$209K Buy
+18,943
New +$354K 0.01% 940
2019
Q2 		– Sell
-25,366
Closed -$421K – 1146
2019
Q1 		$421K Buy
+25,366
New +$481K 0.01% 714

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Voloridge Investment Management's GTHX Position: Q1 2023 in Review

Voloridge Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2023, closing a stake of 150,930 shares — an estimated $820K sold.

Voloridge Investment Management first reported a position in GTHX in Q1 2019 and held it in 10 quarters. The position peaked at $8.26M in Q1 2021. 96 funds tracked by Wall St. Rank hold GTHX as of Q1 2023.

  • Voloridge Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 150,930 G1 Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $820K.
  • Voloridge Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2019 and held it in 10 quarters.
  • Voloridge Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $8.26M in Q1 2021.
  • 96 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.